Citadel Advisors’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.4M | Buy |
334,651
+149,258
| +81% | +$2.59M | ﹤0.01% | 4291 |
|
|
2026
Q1 | $2.94M | Buy |
185,393
+32,782
| +21% | +$573K | ﹤0.01% | 5302 |
|
|
2025
Q4 | $2.71M | Buy |
152,611
+141,386
| +1,260% | +$2.48M | ﹤0.01% | 5356 |
|
|
2025
Q3 | $208K | Sell |
11,225
-33,131
| -75% | -$682K | ﹤0.01% | 11185 |
|
|
2025
Q2 | $953K | Buy |
44,356
+30,380
| +217% | +$657K | ﹤0.01% | 7212 |
|
|
2025
Q1 | $344K | Sell |
13,976
-42,262
| -75% | -$1.04M | ﹤0.01% | 9277 |
|
|
2024
Q4 | $1.3M | Buy |
56,238
+6,137
| +12% | +$153K | ﹤0.01% | 6502 |
|
|
2024
Q3 | $1.36M | Buy |
50,101
+8,270
| +20% | +$251K | ﹤0.01% | 6239 |
|
|
2024
Q2 | $1.2M | Sell |
41,831
-68,336
| -62% | -$2.09M | ﹤0.01% | 6238 |
|
|
2024
Q1 | $3.21M | Buy |
110,167
+48,997
| +80% | +$1.37M | ﹤0.01% | 4660 |
|
|
2023
Q4 | $1.99M | Buy |
61,170
+7,350
| +14% | +$213K | ﹤0.01% | 5360 |
|
|
2023
Q3 | $1.72M | Buy |
53,820
+46,904
| +678% | +$1.81M | ﹤0.01% | 5497 |
|
|
2023
Q2 | $303K | Buy |
6,916
+1,767
| +34% | +$81.5K | ﹤0.01% | 9027 |
|
|
2023
Q1 | $228K | Sell |
5,149
-42,445
| -89% | -$1.88M | ﹤0.01% | 9943 |
|
|
2022
Q4 | $1.89M | Buy |
47,594
+3,778
| +9% | +$157K | ﹤0.01% | 5595 |
|
|
2022
Q3 | $2.02M | Buy |
+43,816
| New | +$2.15M | ﹤0.01% | 5561 |
|
|
2022
Q2 | – | Sell |
-35,421
| Closed | -$1.91M | – | 13521 |
|
|
2022
Q1 | $1.91M | Buy |
35,421
+12,381
| +54% | +$633K | ﹤0.01% | 6182 |
|
|
2021
Q4 | $1.38M | Sell |
23,040
-19,821
| -46% | -$1.23M | ﹤0.01% | 7083 |
|
|
2021
Q3 | $2.81M | Buy |
42,861
+3,234
| +8% | +$210K | ﹤0.01% | 5528 |
|
|
2021
Q2 | $2.5M | Buy |
+39,627
| New | +$2.28M | ﹤0.01% | 6042 |
|
|
2021
Q1 | – | Sell |
-140,561
| Closed | -$6.75M | – | 13482 |
|
|
2020
Q4 | $5.8M | Buy |
140,561
+83,321
| +146% | +$3.82M | ﹤0.01% | 3431 |
|
|
2020
Q3 | $2.63M | Buy |
57,240
+16,875
| +42% | +$783K | ﹤0.01% | 4219 |
|
|
2020
Q2 | $1.77M | Buy |
40,365
+15,710
| +64% | +$707K | ﹤0.01% | 4803 |
|
|
2020
Q1 | $977K | Sell |
24,655
-4,098
| -14% | -$184K | ﹤0.01% | 5375 |
|
|
2019
Q4 | $1.35M | Buy |
28,753
+2,125
| +8% | +$82.3K | ﹤0.01% | 5053 |
|
|
2019
Q3 | $939K | Buy |
26,628
+4,573
| +21% | +$158K | ﹤0.01% | 5705 |
|
|
2019
Q2 | $860K | Buy |
22,055
+10,848
| +97% | +$437K | ﹤0.01% | 5939 |
|
|
2019
Q1 | $495K | Buy |
+11,207
| New | +$426K | ﹤0.01% | 6797 |
|
Other funds holding KIDS
Citadel Advisors's KIDS Position: Q2 2026 in Review
Citadel Advisors increased its OrthoPediatrics (KIDS) stake by 81% in Q2 2026, buying an estimated $2.59M and bringing the position to 334,651 shares worth $6.4M. The position accounts for ﹤0.01% of the portfolio, ranked #4291.
Citadel Advisors first reported a position in KIDS in Q1 2019 and has held it in 28 quarters since. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.
- Citadel Advisors held 334,651 shares of OrthoPediatrics worth $6.4M as of Q2 2026.
- Citadel Advisors bought 149,258 OrthoPediatrics shares in Q2 2026, an estimated $2.59M.
- OrthoPediatrics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4291 holding.
- Citadel Advisors first reported a position in OrthoPediatrics in Q1 2019 and has held it in 28 quarters since.
- 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.